Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AIDS/HIV (Clinical Trials)
Combination Trials Underway, Minorities and Women Sought
November 13th, 1995
The Inter-Company Collaboration for AIDS Drug Development with Parexel International Corporation, Boston, Massachusetts, announced that the second research study for the Collaboration has begun to enroll patients at several research centers in the United States. The study evaluates the ability of two different three-drug combinations to reduce the viral load and produce a sustained increase in CD4 cells in patients who are HIV positive, have a CD4 count between 200 and 500 cells/(mu)L, and who have not previously received antiretroviral therapy. The study will last one year and will enroll 225 patients at 25 clinical centers across the United...
Source: Women's Health Weekly (1995-11-13)
|
